Related Experiment Video
Updated: Jul 11, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
[Which patients with heart failure should be offered cardiac resynchronization?]
R de la Fuente Cid1, F J González Barcala, A Varela Román
1Servicio de Medicina Interna. Complexo Hospitalario Universitario de Santiago. Santiago de Compostela. A Coruña. España. ramondfc@yahoo.es
Revista Clinica Espanola
|October 5, 2007
Summary
Cardiac resynchronization therapy (CRT) improves outcomes for heart failure patients with wide QRS complexes. This treatment offers clinical, hemodynamic, and survival benefits, addressing high mortality rates.
Area of Science:
- Cardiology
- Medical Devices
- Clinical Medicine
Context:
- Chronic heart failure (CHF) is a widespread condition in developed nations.
- Despite advances in drug therapy, CHF mortality remains high.
- A significant portion of CHF patients (NYHA class III-IV, low ejection fraction) exhibit wide QRS, indicating dyssynchronous contraction and increased mortality risk.
Purpose:
- To review clinical trial data on cardiac resynchronization therapy (CRT).
- To present main guideline recommendations for CRT in heart failure management.
- To highlight CRT's role as a complementary treatment for improving CHF prognosis.
Summary:
- Cardiac resynchronization therapy (CRT) utilizes a device to resynchronize ventricular contraction in heart failure patients.
- Clinical studies demonstrate CRT's efficacy in improving clinical status, hemodynamic function, and survival rates.
- CRT is recognized as a valuable adjunctive therapy for selected heart failure patients.
Impact:
- CRT offers a significant therapeutic option to mitigate mortality in heart failure.
- Improved patient outcomes and quality of life are achievable with appropriate CRT implementation.
- Guideline-based application of CRT can optimize treatment strategies for heart failure management.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...